| A01 |

| A01 |

Title

Title

Orthotopic T cell receptor replacement by advanced non-viral cell engineering

| A02 |

| A02 |

Title

Title

One CAR – multiple antigens: Universal CAR-T that are chemically programmed to recognize tumors

| A03 |

| A03 |

Title

Title

Targeting neoantigens in multiple myeloma by TCR-transgenic T cells

|A04|

|A04|

Title

Title

Extending and controlling lymphocyte functionalities by engineering cytokines and their receptors

|A05|

|A05|

Title

Title

Super-resolution microscopy to visualize CAR- and recombinant TCR-T cell receptome and function

|A06|

|A06|

Title

Title

Engineering CAR-T cells against neuroblastoma with synthetic notch receptors to increase tumor-specificity and endogenous immune activation

|A07|

|A07|

Title

Title

Developing polyclonal TCR-T cell therapies using CRISPR base and prime editing

|A08|

|A08|

Title

Title

AI-powered chimeric receptors to overcome therapeutic resistance in myeloma

|B01|

|B01|

Title

Title

CAR T for treatment of acute myeloid leukemia (AML): Chemokine and cytokine targeted switch receptors

Contact Details

Coordination & project management
Dr. Magdalena Nauerth

Trogerstr.30
81675 München

+4989 4140 6887

Contact Form

12 + 9 =